Name Of Nominee<\/strong><\/p>\n<\/td>\n Votes cast FOR<\/strong><\/p>\n<\/td>\n % Votes cast FOR<\/strong><\/p>\n<\/td>\n Votes AGAINST<\/strong><\/p>\n<\/td>\n % Votes AGAINST<\/strong><\/p>\n<\/td>\n<\/tr>\n \nDavid Lazzarato<\/p>\n<\/td>\n \n78,059,502<\/p>\n<\/td>\n \n87.16 %<\/p>\n<\/td>\n \n11,499,873<\/p>\n<\/td>\n \n12.84 %<\/p>\n<\/td>\n<\/tr>\n \nTheresa Yanofsky<\/p>\n<\/td>\n \n76,020,874<\/p>\n<\/td>\n \n84.88 %<\/p>\n<\/td>\n \n13,538,500<\/p>\n<\/td>\n \n15.12 %<\/p>\n<\/td>\n<\/tr>\n \nLuc Mongeau<\/p>\n<\/td>\n \n79,871,589<\/p>\n<\/td>\n \n89.18 %<\/p>\n<\/td>\n \n9,687,785<\/p>\n<\/td>\n \n10.82 %<\/p>\n<\/td>\n<\/tr>\n \nShan Atkins<\/p>\n<\/td>\n \n79,773,303<\/p>\n<\/td>\n \n89.07 %<\/p>\n<\/td>\n \n9,786,072<\/p>\n<\/td>\n \n10.93 %<\/p>\n<\/td>\n<\/tr>\n \nJoseph Bayern<\/p>\n<\/td>\n \n79,713,027<\/p>\n<\/td>\n \n89.01 %<\/p>\n<\/td>\n \n9,846,347<\/p>\n<\/td>\n \n10.99 %<\/p>\n<\/td>\n<\/tr>\n<\/table>\n Appointment of Auditors<\/b><\/p>\n \nShareholders also approved the appointment of MNP LLP (\u201cMNP\u201d) as the Company\u2019s auditor and independent registered public accounting firm for the fiscal year ending March 31, 2027, and authorized the Board or any responsible committee thereof to fix MNP\u2019s remuneration.<\/p>\n Share Consolidation<\/b><\/p>\n \nShareholders adopted a special resolution authorizing an amendment to the articles of the Company to, among other things, consolidate the Company\u2019s issued and outstanding Shares and exchangeable shares of the Company on the basis of a ratio to be determined by the board of directors of the Company (the \u201cBoard\u201d), in its sole discretion, within a range of one post-consolidation share for every five to fifteen outstanding pre-consolidation shares, as more particularly described in the Proxy Statement.<\/p>\n \nThe share consolidation will only be implemented, if at all, upon a determination by the Board that it is in the best interest of the Company and its Shareholders. If the Board does not implement the share consolidation within 12 months of the date of the Meeting, the authority granted to the Board will lapse and be of no further force or effect.<\/p>\n Advance Notice By-Law<\/b><\/p>\n \nShareholders adopted an ordinary resolution ratifying and approving the adoption of the By-Law No. 2 of the Company, which establishes advance notice and certain other requirements for Shareholders proposing director nominations for Shareholder meetings of the Company, as more particularly described in the Proxy Statement.<\/p>\n Renewal of Omnibus Incentive Plan<\/b><\/p>\n \nShareholders adopted an ordinary resolution authorizing and approving all unallocated entitlements under the Company\u2019s Omnibus Incentive Plan, as more particularly described in the Proxy Statement.<\/p>\n Advisory Vote on the Compensation of the Company\u2019s Named Executive Officers<\/b><\/p>\n \nShareholders also adopted an advisory (non-binding) resolution approving the compensation of the Company\u2019s named executive officers (the \u201cNEOs\u201d), as more particularly described in the Proxy Statement.<\/p>\n Advisory Vote on the Frequency of Future Votes on the Compensation of the NEOs<\/b><\/p>\n \nIn the advisory (non-binding) vote on the frequency of future advisory (non-binding) votes on the compensation of the Company\u2019s NEOs, the option to hold a vote every one year received the greatest number of votes from the Shareholders.<\/p>\n \nFor complete results on all matters voted on at the Meeting, please consult the Company\u2019s Report of Voting Results which was filed on the Company\u2019s SEDAR+ profile at www.sedarplus.ca<\/a>, and the Company\u2019s Form 8-K which was filed on EDGAR at www.sec.gov\/edgar<\/a> on October 23, 2026.<\/p>\n About Canopy Growth<\/b><\/p>\n \nCanopy Growth is a leading global company committed to bettering lives through cannabis. With a focus on cultivation excellence, quality, trust, innovation and disciplined execution, Canopy Growth is a consumer-centric company serving patients, consumers and partners alike.<\/p>\n \nThe Company\u2019s portfolio of owned and licensed brands, including Tweed, 7ACRES, DOJA, Deep Space, DeeLish, Claybourne, MTL Cannabis, Low Key by MTL and R\u2019belle, as well as category-defining Storz & Bickel, delivers innovative cannabis products to consumers across Canada and beyond. It is also Canada\u2019s leading provider of medical cannabis services through Spectrum Therapeutics, Abba Medix, Apollo, and Canada House Clinics.<\/p>\n \nThe Company also holds an unconsolidated, non-controlling interest in Canopy USA, LLC, which provides exposure to the U.S. THC market.<\/p>\n \nGuided by its commitment to leadership, excellence, trust and innovation, Canopy Growth is working to shape a future where the plant is trusted for its ability to better lives.<\/p>\n \nFor more information visit www.canopygrowth.com<\/a>.<\/p>\n View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20261026936399\/en\/<\/a><\/span><\/p>\n Media Contact:<\/b>media@canopygrowth.com KEYWORDS:<\/b> North America Canada<\/p>\n INDUSTRY KEYWORDS:<\/b> Alternative Medicine Cannabis Retail Health Specialty Natural Resources<\/p>\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n <\/p>\n
\n<\/a>
Investor Contact:<\/b>invest@canopygrowth.com<\/a><\/p>\n
![\"Logo\"](\"https:\/\/mms.businesswire.com\/media\/20261026936399\/en\/2875781\/3\/Canopy_Logo_CMYK.jpg\"){kind=logo}
<\/td>\n<\/tr>\n